Genic Co., Ltd. (KOSDAQ:123330)

Genic Statistics

Total Valuation

Genic has a market cap or net worth of KRW 207.75 billion. The enterprise value is 206.06 billion.

Market Cap	207.75B
Enterprise Value	206.06B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Genic has 7.82 million shares outstanding. The number of shares has increased by 13.68% in one year.

Current Share Class	7.82M
Shares Outstanding	7.82M
Shares Change (YoY)	+13.68%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.10%
Float	4.71M

Valuation Ratios

The trailing PE ratio is 13.86.

PE Ratio	13.86
Forward PE	n/a
PS Ratio	2.70
PB Ratio	7.01
P/TBV Ratio	7.01
P/FCF Ratio	31.98
P/OCF Ratio	23.72
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.38, with an EV/FCF ratio of 31.72.

EV / Earnings	13.81
EV / Sales	2.67
EV / EBITDA	12.38
EV / EBIT	13.80
EV / FCF	31.72

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.20.

Current Ratio	1.73
Quick Ratio	1.27
Debt / Equity	0.20
Debt / EBITDA	0.36
Debt / FCF	0.92
Interest Coverage	36.16

Financial Efficiency

Return on equity (ROE) is 72.14% and return on invested capital (ROIC) is 32.50%.

Return on Equity (ROE)	72.14%
Return on Assets (ROA)	23.58%
Return on Invested Capital (ROIC)	32.50%
Return on Capital Employed (ROCE)	49.11%
Revenue Per Employee	237.80M
Profits Per Employee	46.04M
Employee Count	324
Asset Turnover	1.95
Inventory Turnover	7.58

Taxes

Income Tax	-361.52M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +67.09% in the last 52 weeks. The beta is 1.69, so Genic's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	+67.09%
50-Day Moving Average	33,348.00
200-Day Moving Average	27,463.00
Relative Strength Index (RSI)	33.51
Average Volume (20 Days)	67,463

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genic had revenue of KRW 77.05 billion and earned 14.92 billion in profits. Earnings per share was 1,915.62.

Revenue	77.05B
Gross Profit	21.61B
Operating Income	14.94B
Pretax Income	14.56B
Net Income	14.92B
EBITDA	16.65B
EBIT	14.94B
Earnings Per Share (EPS)	1,915.62

Balance Sheet

The company has 7.65 billion in cash and 5.96 billion in debt, giving a net cash position of 1.69 billion or 215.63 per share.

Cash & Cash Equivalents	7.65B
Total Debt	5.96B
Net Cash	1.69B
Net Cash Per Share	215.63
Equity (Book Value)	29.64B
Book Value Per Share	3,787.68
Working Capital	14.31B

Cash Flow

In the last 12 months, operating cash flow was 8.76 billion and capital expenditures -2.26 billion, giving a free cash flow of 6.50 billion.

Operating Cash Flow	8.76B
Capital Expenditures	-2.26B
Free Cash Flow	6.50B
FCF Per Share	830.17

Margins

Gross margin is 28.05%, with operating and profit margins of 19.39% and 19.36%.

Gross Margin	28.05%
Operating Margin	19.39%
Pretax Margin	18.89%
Profit Margin	19.36%
EBITDA Margin	21.61%
EBIT Margin	19.39%
FCF Margin	8.43%

Dividends & Yields

Genic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.68%
Shareholder Yield	n/a
Earnings Yield	7.18%
FCF Yield	3.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.0103113.

Last Split Date	Dec 27, 2017
Split Type	Forward
Split Ratio	1.0103113

Scores

Genic has an Altman Z-Score of 7.43 and a Piotroski F-Score of 6.

Altman Z-Score	7.43
Piotroski F-Score	6